Sculptor

Sculptor is a global asset management firm founded in 1994 and headquartered in New York City. The firm specializes in alternative investments, utilizing a multi-strategy approach that encompasses various global investment strategies, including long/short equity, special situations, convertible and derivative arbitrage, structured credit, and merger arbitrage. Sculptor's corporate credit strategies involve high-yield debt investments in distressed businesses, bank loans, and senior secured debt, as well as mezzanine financing and innovative capital solutions. With offices in New York, London, and Hong Kong, Sculptor manages approximately $37.5 billion in assets for an institutional client base as of September 2021.

Daniel Och

CEO

Mark Schwartz

Head of Gaming Investments, Executive Managing Director

10 past transactions

Therme Group

Private Equity Round in 2025
Therme Group is a global technology company. Their culture and character are defined by excellence, integrity and teamwork, all of which have been at the core of Therme Group since its inception. This has enabled incredible achievements, including bringing Therme to Romania, where they created the largest European leisure facility ever developed on a Greenfield site. Highly successful and with more than 1.2 million visitors in its first year of operation, Therme Bucharest embodies their vision of wellbeing for all.

Land's End

Post in 2024
Land's End is a multichannel retail company. The company operates through two segments, Direct and Retail. It offers casual clothing, accessories, footwear, and home products. The company sells its products through its e-commerce Websites, direct mail catalogs, and Lands’ End Shops at Sears. Land’s End was founded in 1963 and is headquartered in the United States.

Club Car Wash

Acquisition in 2023
Club Car Wash is a motor vehicle manufacturing firm that focuses on car washing, account management, and car services.

Sharp peptide

Series A in 2023
Sharp peptide life is a manufacturer and seller of fungus peptide liquid.

Grove Collaborative

Post in 2022
Grove Collaborative, Inc. is an online retailer based in San Francisco, California, specializing in home and personal care products. The company offers a wide range of items, including household cleaners, personal care products, baby and kids' items, and pet supplies. Grove Collaborative, formerly known as ePantry LLC, was founded in 2012 and became a Certified B Corporation in 2016, emphasizing its commitment to environmental and social responsibility. The company is recognized for its flagship brand, Grove Co., and other sustainable lines such as Peach and Superbloom. Grove Collaborative has pioneered the zero-waste home care category and is a leader in offering products made with clean ingredients, sustainability in mind, and ethical manufacturing practices. As a public benefit corporation, Grove aims to eliminate plastic use and is the first plastic neutral retailer globally, with a goal of becoming 100% plastic-free by 2025.

Grove Collaborative

Venture Round in 2020
Grove Collaborative, Inc. is an online retailer based in San Francisco, California, specializing in home and personal care products. The company offers a wide range of items, including household cleaners, personal care products, baby and kids' items, and pet supplies. Grove Collaborative, formerly known as ePantry LLC, was founded in 2012 and became a Certified B Corporation in 2016, emphasizing its commitment to environmental and social responsibility. The company is recognized for its flagship brand, Grove Co., and other sustainable lines such as Peach and Superbloom. Grove Collaborative has pioneered the zero-waste home care category and is a leader in offering products made with clean ingredients, sustainability in mind, and ethical manufacturing practices. As a public benefit corporation, Grove aims to eliminate plastic use and is the first plastic neutral retailer globally, with a goal of becoming 100% plastic-free by 2025.

Blue Source

Private Equity Round in 2008
Blue Source is a climate change offset group based in North America, focused on publicly registered third-party verified ghg offsets, historical ghg offset sales and ghg offset types.

FibroGen

Venture Round in 2005
FibroGen, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutics to address significant unmet medical needs. The company is advancing Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylases, which is in Phase III clinical development for treating anemia in chronic kidney disease in the United States and Europe, and in Phase II/III development for anemia associated with myelodysplastic syndromes in China. Additionally, FibroGen is developing Pamrevlumab, a human monoclonal antibody that targets connective tissue growth factor, currently in Phase III trials for idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, along with a Phase II trial for Duchenne muscular dystrophy. The company has established collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. Founded in 1993 and headquartered in San Francisco, California, FibroGen generates most of its revenue through these collaborative partnerships.

Acuity Pharmaceuticals

Series B in 2004
Acuity Pharmaceuticals is a pharmaceutical company that is focused on the treatment and prevention of ophthalmic diseases. It develops treatments for age-related macular degeneration and diabetic retinopathy. The company offers Cand5, a clinical compound that is able to shut down vascular endothelial growth factor. Acuity Pharmaceuticals was acquired by OPKO Health in June 2011. Acuity Pharmaceuticals was founded in 2007 and is based in Philadelphia, Pennsylvania.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.